切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2019, Vol. 08 ›› Issue (04) : 159 -162. doi: 10.3877/cma.j.issn.2095-3216.2019.04.004

所属专题: 文献

论著

乙型肝炎病毒相关膜性肾病患者抗血清磷脂酶A2受体-IgG特点及其相关因素的临床研究
戴沛霖1, 杨悦2, 涂天琪3, 李文歌3,()   
  1. 1. 100083 北京大学医学部中日友好临床医学院;100029 国家卫健委中日友好医院 肾病科
    2. 100029 国家卫健委中日友好医院 肾病科
  • 收稿日期:2018-12-19 出版日期:2019-08-28
  • 通信作者: 李文歌

Characteristics of serum anti-phospholipase A2 receptor-IgG and its related factors in patients with hepatitis B virus-associated membranous nephropathy

Peilin Dai1, Yue Yang2, Tianqi Tu3, Wenge Li3,()   

  1. 1. China-Japan Friendship Clinical Medical College of Peking University, Beijing 100083, China; Department of Nephropathy, China-Japan Friendship Hospital of National Health Commission, Beijing 100029, China
    2. Department of Nephropathy, China-Japan Friendship Hospital of National Health Commission, Beijing 100029; China
    3. China-Japan Friendship Clinical Medical College of Peking University, Beijing 100083, China; Department of Nephropathy, China-Japan Friendship Hospital of National Health Commission, Beijing 100029; China
  • Received:2018-12-19 Published:2019-08-28
  • Corresponding author: Wenge Li
  • About author:
    Corresponding author: Li Wenge, Email:
引用本文:

戴沛霖, 杨悦, 涂天琪, 李文歌. 乙型肝炎病毒相关膜性肾病患者抗血清磷脂酶A2受体-IgG特点及其相关因素的临床研究[J]. 中华肾病研究电子杂志, 2019, 08(04): 159-162.

Peilin Dai, Yue Yang, Tianqi Tu, Wenge Li. Characteristics of serum anti-phospholipase A2 receptor-IgG and its related factors in patients with hepatitis B virus-associated membranous nephropathy[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2019, 08(04): 159-162.

目的

研究乙型肝炎病毒相关膜性肾病(HBV-MN)患者血清抗磷脂酶A2受体(PLA2R)-IgG阳性率,分析与PLA2R-IgG滴度相关的因素。

方法

本研究纳入经肾穿刺活检确诊的HBV-MN患者108例,检测血清PLA2R-IgG滴度、肌酐、白蛋白和24 h尿蛋白定量等,计算肾小球滤过率,分别统计患者肾活检组织中PLA2R及免疫荧光IgG、C3、C1q及IgG亚型阳性率,分析年龄、性别、蛋白尿与血清中和肾活检组织中PLA2R-IgG检测结果的关系。

结果

108例HBV-MN患者中,血清PLA2R-IgG阳性率为37%,肾组织PLA2R阳性率54.6%,血清PLA2R-IgG的阳性率和滴度与年龄、性别无统计学相关性(P>0.05),与尿蛋白水平相关(χ2=9.159,P=0.010;χ2=11.327,P=0.004);尿蛋白>3.5 g/d组患者PLA2R-IgG阳性率显著高于尿蛋白<1g/d及1~3.5 g/d组(Z=2.863,P=0.012和Z=2.356,P=0.049)。

结论

HBV-MN患者中PLA2R-IgG阳性率较高,阳性率及滴度均与蛋白尿水平相关,尿蛋白越多,阳性率和滴度也随之升高。

Objective

To study the positive rate of serum anti-phospholipase A2 receptor (PLA2R)-IgG in patients with hepatitis B virus-associated membranous nephropathy (HBV-MN), and to analyze the factors related to anti-PLA2R-IgG titer.

Methods

In this study, 108 patients with HBV-MN diagnosed by renal biopsy were enrolled. The titers of serum PLA2R-IgG, serum creatinine, and serum albumin, as well as 24 h urine protein were measured. The glomerular filtration rate was calculated. The positive rates of PLA2R expression and the immunofluorescence of IgG, C3, and C1q besides IgG subtypes in the renal biopsy tissues were counted. And the relationships between age, gender, or proteinuria and anti-PLA2R-IgG detection results from serum and renal biopsies were analyzed.

Results

Among the 108 patients with HBV-MN, the positive rate of serum anti-PLA2R-IgG was 37%, and the positive rate of PLA2R in the renal tissues was 54.6%. The positive rate and titer of serum anti-PLA2R-IgG were not statistically correlated with age and gender (P>0.05), but were correlated with the urinary protein levels (χ2=9.159, P=0.010; χ2=11.327, P=0.004). patients with urinary protein>3.5 g/d have significantly higher positive rate than patients with urinary protein <1 g/d and 1-3.5 g/d group (Z=2.863, P=0.012 and Z=2.356, P=0.049).

Conclusion

The positive rate of anti-PLA2R-IgG was high in the HBV-MN patients, and its positive rate and titer were associated with the proteinuria level. The higher proteinuria level, the higher positive rate and titer of anti-PLA2R-IgG.

表1 入选患者临床特征和检测数据(n=108)
图1 HBV-MN肾小球及肾小管损伤情况(PASM染色,400×)
图2 HBV-MN患者肾组织切片免疫荧光染色(400×)
图3 HBV-MN患者蛋白尿与血清PLA2R-IgG
[1]
Beck LH, Jr.Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy [J]. N Engl J Med, 2009, 361(1): 11-21.
[2]
Geneva: World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [EB/OL]. 2015:

URL    
[3]
Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents [J]. MMWR Recomm Rep, 2005, 54(RR-16): 1-31.
[4]
Yang Y, Zhang Z, Zhuo L, et al. The spectrum of biopsy-proven glomerular disease in China: a systematic review [J]. Chin Med J (Engl), 2018, 131(6): 731-735.
[5]
Pourcine F, Dahan K, Mihout F, et al. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: a single-centre study over 14 years [J]. PLoS One, 2017, 12(3): e0173201.
[6]
Xie Q, Li Y, Xue J, et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy [J]. Am J Nephrol, 2015, 41(4-5): 345-353.
[7]
Lin L, Wang WM, Pan XX, et al. Biomarkers to detect membranous nephropathy in Chinese patients [J]. Oncotarget, 2016, 7(42): 67868-67879.
[8]
Wang J, Cui Z, Lu J, et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy [J]. Clin J Am Soc Nephrol, 2017, 12(10): 1642-1651.
[9]
Hofstra JM, Beck LH, Jr. Beck DM, et al. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy [J]. Clin J Am Soc Nephrol, 2011, 6(6): 1286-1291.
[10]
Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy [J]. J Am Soc Nephrol, 2014, 25(6): 1357-1366.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 蒋佳纯, 王晓冰, 陈培荣, 许世豪. 血清学指标联合常规超声及超声造影评分诊断原发性干燥综合征的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 622-630.
[3] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[4] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[5] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[6] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[7] 杨雪, 张伟, 尚培中, 宋创业, 尚丹丹, 张蔚. 胆囊十二指肠瘘结石经瘘口排出后自愈一例报道[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 707-708.
[8] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[9] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[10] 赵立力, 王魁向, 张小冲, 李志远. 血沉与C-反应蛋白比值在假体周围感染中的诊断价值分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 351-355.
[11] 吴凤芸, 滕鑫, 刘连娟. 高帧频超声造影与增强磁共振对不同直径原发性高分化肝细胞癌的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 404-408.
[12] 孙欣欣, 刘军, 陈超伍, 孙超. 超声内镜引导细针穿刺抽吸术在胰腺占位性病变中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 418-421.
[13] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[14] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要